Updates matching "Access to Health Care"

Our organizations, representing patients with serious health conditions, condemn Judge Kacsmaryk’s decision which threatens to restrict access to a Food and Drug Administration (FDA)- approved medication and other treatments.

LD1577 Would Allow More Mainers to Access Routinely Recommended Testing That Allows Doctors to Personalize Health Care Treatments

More than a dozen patient groups representing millions of Americans with serious and chronic health conditions are urging the U.S. Court of Appeals for the Fifth Circuit to preserve protections in the Affordable Care Act (ACA) for Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ+) patients receiving health care services in the case of Neese vs. Becerra .

WASHINGTON, D.C. – A bill introduced in the House today aims to improve future equitable access to new and innovative cancer screenings among Medicare beneficiaries in order to increase early detection of more cancers for more individuals. The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act would allow

Today U.S. District Court Judge Reed O’Connor issued his decision on the remedy for his September 2022 ruling that the requirement that Affordable Care Act (ACA)-compliant health insurers cover U.S. Preventive Services Task Force (USPSTF)-recommended services without cost sharing violates the U.S. Constitution.

The PSA Screening for HIM Act was introduced in the U.S. House of Representatives on March 28, 2023. This bipartisan legislative proposal would waive cost-sharing requirements for men with the highest risk of prostate cancer, focusing on Black men and those with a family history of the disease.

ANNAPOLIS, MD – MARCH 27, 2023 – Lance Kilpatrick has joined the American Cancer Society Cancer Action Network (ACS CAN) as the Government Relations Director in Maryland, Delaware and Washington, D.C. In this role, Kilpatrick will lead ACS CAN’s efforts to advance legislation and public policies to reduce cancer. “Cancer

Rhode Island lawmakers have taken the first step towards ensuring cancer patients and others with chronic disease are protected from excessive prescription drug costs.